Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

[Catatonia and neuroleptic malignant syndrome in view of a psychopathological and pathophysiological overlap: a brief review].

Asztalos Z, Egervári L, Andrássy G, Faludi G, Frecska E.

Neuropsychopharmacol Hung. 2014 Mar;16(1):19-28. Review. Hungarian.

2.

Catatonia and its treatment.

Rosebush PI, Mazurek MF.

Schizophr Bull. 2010 Mar;36(2):239-42. doi: 10.1093/schbul/sbp141. Epub 2009 Dec 7. Review.

3.

[Catatonia, malignant neuroleptic syndrome and myositis ossificans].

Topka H, Buchkremer G.

Nervenarzt. 1996 May;67(5):413-7. German.

PMID:
9005354
4.

Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome.

Lee JW.

J Clin Psychopharmacol. 2010 Feb;30(1):3-10. doi: 10.1097/JCP.0b013e3181c9bfe6.

PMID:
20075641
5.

[Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports].

Luchini F, Lattanzi L, Bartolommei N, Cosentino L, Casamassima F, Litta A, Mauri M, Cassano GB.

Riv Psichiatr. 2012 Mar-Apr;47(2):178-85. doi: 10.1708/1069.11721. Italian.

PMID:
22622253
6.

Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.

Paparrigopoulos T, Tzavellas E, Ferentinos P, Mourikis I, Liappas J.

World J Biol Psychiatry. 2009;10(1):70-3. doi: 10.1080/15622970701287369.

PMID:
19673089
7.

Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology.

Northoff G.

J Neural Transm (Vienna). 2002 Dec;109(12):1453-67. Review.

PMID:
12486486
8.

[Are catatonia and neuroleptic malignant syndrome related conditions?].

Vesperini S, Papetti F, Pringuey D.

Encephale. 2010 Apr;36(2):105-10. doi: 10.1016/j.encep.2009.03.009. Epub 2009 Aug 28. Review. French.

PMID:
20434626
9.

Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia.

Komatsu T, Nomura T, Takami H, Sakamoto S, Mizuno K, Sekii H, Hatta K, Sugita M.

Intern Med. 2016;55(19):2893-2897. Epub 2016 Oct 1.

10.

Neuroleptic catatonia and its relationship to psychogenic catatonia.

Fricchione GL.

Biol Psychiatry. 1985 Mar;20(3):304-13.

PMID:
2858225
11.

Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports.

Luchini F, Lattanzi L, Bartolommei N, Cosentino L, Litta A, Kansky C, Mauri M, Cassano GB, Fagiolini A, Casamassima F.

J Nerv Ment Dis. 2013 Jan;201(1):36-42. doi: 10.1097/NMD.0b013e31827ab24b.

PMID:
23274293
12.

[Catatonia: resurgence of a concept. A review of the international literature].

Pommepuy N, Januel D.

Encephale. 2002 Nov-Dec;28(6 Pt 1):481-92. Review. French.

PMID:
12506260
13.

Catatonia: a syndrome appears, disappears, and is rediscovered.

Fink M.

Can J Psychiatry. 2009 Jul;54(7):437-45. Review.

PMID:
19660165
14.
15.

ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome.

Addonizio G, Susman VL.

J Clin Psychiatry. 1987 Mar;48(3):102-5.

PMID:
2880837
16.

["Catatonic dilemma". Therapy with lorazepam and clozapine].

Lausberg H, Hellweg R.

Nervenarzt. 1998 Sep;69(9):818-22. German.

PMID:
9789276
17.

Neuroleptic malignant syndrome and its controversies.

Margetić B, Aukst-Margetić B.

Pharmacoepidemiol Drug Saf. 2010 May;19(5):429-35. doi: 10.1002/pds.1937. Review.

PMID:
20306454
18.

Catatonia. 2: Diagnosis, management and prognosis.

Clark T, Rickards H.

Hosp Med. 1999 Nov;60(11):812-4. Review.

PMID:
10707192
19.

[Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].

Askenazy F, Dor E, Benoit M, Dupuis G, Serret S, Myquel M, Seddiki Y.

Encephale. 2010 Feb;36(1):46-53. doi: 10.1016/j.encep.2009.01.006. Epub 2009 May 12. French.

PMID:
20159196
20.

Catatonic schizophrenia: therapeutic challenges and potentially a new role for electroconvulsive therapy?

Philbin D, Mulryan D, O'Grady M.

BMJ Case Rep. 2013 Jul 29;2013. pii: bcr2013009153. doi: 10.1136/bcr-2013-009153.

Supplemental Content

Support Center